Articles By Nushin Rashidian
Q&A: Three Questions for Sanjay Gupta on CBD
On Sunday, CNN will air Gupta’s fifth documentary about cannabis as medicine. Cannabis Wire caught up with Gupta to learn more about his thoughts on the so-called CBD craze and forthcoming FDA regulations.
CannTrust Licenses Suspended, Shopify Enters US, Canopy Ex-CEO’s Next Gigs, & More…
A roundup of the latest major industry moves across the globe.
Scoop: What Did Canopy Growth Say to the White House About USDA Hemp Regs?
Last week, the global cannabis giant gave input on everything from THC testing, to interstate transportation, to seed certification.
Q&A: What Does Silicon Valley’s PAX Have Planned in Canada?
Cannabis Wire spoke with PAX’s first general manager for Canada about new markets, shifting consumer preferences, and the opportunities afforded by federal legalization.
FDA Extends Public Comment on Products Containing Cannabis
The agency, which will determine the future of the CBD industry, also provided an update on its information gathering. And yesterday, Canada’s health officials initiated a somewhat similar process.
Canada Unveils Long-Awaited Regulations for Edible Cannabis Products
Cannabis buds have been for sale across the country since October. But officials wanted to take their time crafting rules for more potent products, like edibles and concentrates.
Nevada Governor’s Transparency Move Reveals Big Names in State Cannabis Industry
Chicago-based Green Thumb Industries looms large with 30 licenses.
Which Big Banks Are Thinking About the SAFE Banking Act?
Mainstream banks like Wells Fargo and Citigroup added a cannabis banking measure to their first quarter lobbying report.
History Repeating
Hemp is legal. Cannabis legalization is close behind. How did we get here? This 4/20, unwind with this excerpt from A New Leaf: The End of Cannabis Prohibition.
